Envision Pharma Group

Fairfield, United States Founded: 2001 • Age: 25 yrs Acquired By GHO Capital Partners
Compliant global publication planning is offered for life sciences.

About Envision Pharma Group

Envision Pharma Group is a Healthcare company based in Fairfield (United States) founded in 2001, and was acquired by GHO Capital Partners in July 2016. Compliant global publication planning is offered for life sciences. The company has 494 employees. Envision Pharma Group has completed 6 acquisitions, including 90TEN, Medtrack and OKRA. Its website envisionpharmagroup.com draws about 14 thousand monthly visits. Envision Pharma Group offers products and services including EnvisionOne, iEnvision, and OKRA.ai. Its focus areas include HealthTech, Life Sciences Tech, GRC Solutions and Diversified. Its competitors include MetricStream, Octagon Research and MasterControl; 2 of its 3 listed competitors have raised funding.

Company details

The Envision Pharma Group is an innovative scientific communications and technology company, focused on the life science industry. They work with clients, authors, and the medical publishing community to develop and execute evidence-based communication programs in a transparent and compliant manner. The team members are industry leaders who are often consulted in publications policy, process, metrics, change management, and technology. To match the needs of clients, they offer flexibility in business approach in team design and make up, payment models, offering whole solutions or key components, transfer of knowledge, or project timescales. Claim to be an industry leader in global publication planning, combining strategic consulting, market access medical communications expertise, with integrated industry-leading technology solutions including Datavision, Visiontracker and Clear. Acquired Alligent (2015) Proscribe (2014).

Key Metrics

Products & Services of Envision Pharma Group

Envision Pharma Group offers a comprehensive portfolio of products and services, including EnvisionOne, iEnvision, and OKRA.ai.

EnvisionOne
SaaS Platform

SaaS platform for medical information and communications elevation

iEnvision
Workflow Platform

Medical affairs software for efficiency and compliance management

OKRA.ai
AI Solution

AI tool for life sciences commercialization and medical insights

Investors in Envision Pharma Group

Envision Pharma Group has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Ardian and GHO Capital.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Private investment firm specializing in markets and partnerships.
ardian.com
Specialist healthcare investment advisory services are provided by GHO Capital.
ghocapital.comLondon, United Kingdom
Premium access

Investor details for Envision Pharma Group

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Envision Pharma Group

215 people are tracked at Envision Pharma Group (91 in leadership, 124 in team); the tracked headcount is 494.

NameRoleGroup
Veronica Meza
Account DirectorLeadership
Philip Matthews Ph.D., Cmpp
VP - Portfolio Director & Team LeadLeadership
Julie Pearce
Account DirectorLeadership
Sarah Kaiser
Account DirectorLeadership
Kylie Turner
Global Associate Director, Facilities & OperationsLeadership
Lauren Scott Zoeller
Vp, Portfolio Director And Scientific Team LeadLeadership
Gary Dever
Vp, Portfolio Director & Team LeadLeadership
Margit Rezabek
Senior Scientific Director, Content SpecialistLeadership
Laura Samatova
Director, Transformation And Enterprise OperationsLeadership
Dr. Shweta Vadnerkar
Senior Scientific Director & Team LeadLeadership
Linda Gorman
Director Operational ExcellenceLeadership
Aaron Fisher
Director Service ManagmentLeadership
Angela Pozo Ramajo
Senior Scientific Director, Professional DevelopmentLeadership
Karen Pemberton Cmpp
Scientific Director, Account LeadLeadership
Alex Cowley
Director Strategic Programs - Business And Technology StrategyLeadership
Peter Kersting
Global Director Of Information SecurityLeadership
Lauren Scott
Vp, Portfolio Director And Scientific Team LeadLeadership
Joe Zeleski
Director, Data Solutions & InsightsLeadership
Karen Spach
(vp) Portfolio Director & Team LeadLeadership
Sean Harrison
Head Of Client Solutions, Envision Medical CommunicationsLeadership

195 more people are available in the full profile.

Premium access

Complete people profiles for Envision Pharma Group

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Envision Pharma Group

Envision Pharma Group has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include 90TEN, Medtrack and OKRA.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
AI powered platform specializing in healthcare and life sciences
okra.aiCambridge, United Kingdom2016Feb 2023β€’β€’β€’β€’
Web-based audit and compliance software for pharma companies is provided.
dodoc.comBoston, United States2014Mar 2021β€’β€’β€’β€’
Market intelligence and commercialization services are provided by Two Labs.
twolabs.comPowell, United States2003Nov 2020β€’β€’β€’β€’
Health education programs and communication strategies are developed and delivered.
90ten.co.ukLondon, United Kingdom2001Apr 2020β€’β€’β€’β€’
Biopharmaceutical intelligence is delivered via a web-based database platform.
medtrack.comLondon, United Kingdom1998Jul 2014β€’β€’β€’β€’
Property valuation and conveyancing services are provided by Proscribe.
proscribe.com.auNorth Ryde, Australia2000Feb 2014β€’β€’β€’β€’
Premium access

Complete acquisition details for Envision Pharma Group

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Envision Pharma Group

8 dated milestones of Envision Pharma Group across 22 years, from founding to its latest funding, stage changes and deals.

  1. Founded Envision Pharma Group is founded.
  2. Acquisition Acquires Proscribe.
  3. Acquisition Acquires Medtrack.
  4. Exit Acquired by GHO Capital Partners.
  5. Acquisition Acquires 90TEN.
  6. Acquisition Acquires Two Labs.
  7. Acquisition Acquires doDOC.
  8. Acquisition Acquires OKRA.

Competitors of Envision Pharma Group

Envision Pharma Group has 3 listed competitors in our database, 2 of them funded. They include MetricStream, Octagon Research and MasterControl.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
metricstream.com1999San Jose, United States$213.35M515
Cloud-based regulatory solutions are provided for financial institutions.
octagonresearch.com1999Wayne, United States406
Clinical and regulatory information management software is provided for pharmaceuticals.
mastercontrol.com1994Salt Lake, United States$150M560
Provider of governance, risk and compliance solutions for life sciences industries
Premium access

Detailed competitors of Envision Pharma Group

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Envision Pharma Group

The website of Envision Pharma Group (envisionpharmagroup.com) receives about 14.5K visits a month and ranks #1,461,153 among all websites worldwide, #1,908 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    14.5K

    ▲ 19.6% vs previous month

  • Unique visitors
    5.4K

    per month

  • Global rank
    #1,461,153

    among all websites

  • Category rank
    #1,908

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Envision Pharma Group. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
biomapas.com
100%
680.7K#2,569,977View details
medthink.com
93%
2K#6,295,881View details
clinicalleader.com
86%
680.7K#948,222View details
medicalaffairs.org
medicalaffairs.org
86%
#1,152,217–
iqvia.com
74%
1.2M#45,953View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 10 similar websites and full traffic analytics for Envision Pharma Group

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 10 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Envision Pharma Group (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Envision Pharma Group

Premium access

Complete news archive for Envision Pharma Group

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Envision Pharma Group

Envision Pharma Group was founded in 2001.

Envision Pharma Group is headquartered in Fairfield, United States.

Envision Pharma Group has 494 employees.

The Envision Pharma Group is an innovative scientific communications and technology company, focused on the life science industry. They work with clients, authors, and the medical publishing community to develop and execute evidence-based communication programs in a transparent and compliant manner. The team members are industry leaders who are often consulted in publications policy, process, metrics, change management, and technology. To match the needs of clients, they offer flexibility in business approach in team design and make up, payment models, offering whole solutions or key components, transfer of knowledge, or project timescales. Claim to be an industry leader in global publication planning, combining strategic consulting, market access medical communications expertise, with integrated industry-leading technology solutions including Datavision, Visiontracker and Clear. Acquired Alligent (2015) Proscribe (2014).

Envision Pharma Group's top competitors include MasterControl, Octagon Research and MetricStream.

Envision Pharma Group offers EnvisionOne, iEnvision, and OKRA.ai.

Envision Pharma Group has made 6 acquisitions, including 90TEN, Medtrack, and OKRA.

Envision Pharma Group has 2 investors. Key investors include Ardian, and GHO Capital.

Yes. Envision Pharma Group was acquired by GHO Capital Partners in July 2016.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available